Dynatronics Co. (NASDAQ:DYNT) major shareholder Stuart Essig acquired 27,455 shares of the company’s stock in a transaction dated Wednesday, January 3rd. The shares were bought at an average cost of $2.77 per share, with a total value of $76,050.35. Following the completion of the acquisition, the insider now directly owns 856,169 shares in the company, valued at approximately $2,371,588.13. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Large shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.
Dynatronics Co. (DYNT) traded up $0.06 during midday trading on Thursday, hitting $3.05. 8,400 shares of the stock were exchanged, compared to its average volume of 6,333. Dynatronics Co. has a 52 week low of $2.10 and a 52 week high of $3.75. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.46 and a quick ratio of 0.92. The company has a market cap of $14.52, a P/E ratio of -2.75 and a beta of -0.14.
Dynatronics (NASDAQ:DYNT) last posted its quarterly earnings data on Tuesday, November 14th. The medical equipment provider reported $0.00 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.08. Dynatronics had a negative net margin of 3.42% and a negative return on equity of 45.78%. The company had revenue of $12.80 million during the quarter. sell-side analysts predict that Dynatronics Co. will post -0.09 earnings per share for the current fiscal year.
An institutional investor recently bought a new position in Dynatronics stock. First Light Asset Management LLC acquired a new position in shares of Dynatronics Co. (NASDAQ:DYNT) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 100,000 shares of the medical equipment provider’s stock, valued at approximately $280,000. First Light Asset Management LLC owned about 2.72% of Dynatronics as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 18.17% of the company’s stock.
Separately, Zacks Investment Research raised shares of Dynatronics from a “hold” rating to a “buy” rating and set a $3.25 price objective for the company in a report on Monday.
TRADEMARK VIOLATION NOTICE: “Stuart Essig Acquires 27,455 Shares of Dynatronics Co. (DYNT) Stock” was originally published by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this piece on another site, it was illegally stolen and reposted in violation of international copyright and trademark law. The legal version of this piece can be viewed at https://transcriptdaily.com/2018/01/05/stuart-essig-acquires-27455-shares-of-dynatronics-co-dynt-stock.html.
Dynatronics Company Profile
Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals.
Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.